BDBM663078 US20240109898, Compound Z-5::US20240109898, Compound Z-5-1::US20240109898, Compound Z-5-2
SMILES CC(C1CC1)c1cc(N[C@H]2CC[C@H](N)C2)n2nccc2n1
InChI Key InChIKey=SZWIEOISRBXPJU-UHFFFAOYSA-N
Data 9 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 9 hits for monomerid = 663078
TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Affinity DataIC50: 17nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Affinity DataIC50: 23nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Affinity DataIC50: 7nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Affinity DataIC50: 2.20E+3nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Affinity DataIC50: 3.99E+3nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Affinity DataIC50: 1.43E+3nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Affinity DataIC50: 9.13E+3nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Affinity DataIC50: 838nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Shanghai Haiyan Pharmaceutical Technology Co.
US Patent
Affinity DataIC50: 887nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
